Myung-Ok Park,Choun-Ki Joo,Jun-Sub Choi,Kyung-A Kim,Sung-Sik Bang
申请号：
US12674244
公开号：
US08242094B2
申请日:
2008.08.22
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to a siRNA which targets mRNA of the NF-Kappa B p105 gene to cause its degradation by RNAi induction. In addition, the present invention provides a pharmaceutical composition for the treatment of diseases associated with aberrant cell proliferation and migration, comprising the siRNA and delivery vehicle capable of intracellular delivery of the same.
